Company Pivotal Therapeutics Inc. Other OTC
Equities
PVTTF
CA72582E1043
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2013 | Weight | 2014 | Weight | Delta |
---|---|---|---|---|---|
Omega-3 Pharmaceutical Products
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -5.76% |
Sales per region
USD in Million | 2013 | Weight | 2014 | Weight | Delta |
---|---|---|---|---|---|
United States
99.2
%
| 0 | 97.2 % | 0 | 99.2 % | -3.83% |
Canada
0.8
%
| 0 | 2.8 % | 0 | 0.8 % | -74.01% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 01/10/01 | |
George Jackowski
FOU | Founder | - | 01/10/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
George Jackowski
FOU | Founder | - | 01/10/01 |
John Gebhardt
CHM | Chairman | 77 | 22/11/22 |
Founder | - | 01/10/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 96,566,669 | 96,566,669 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Pivotal Therapeutics, Inc.
30 Pennsylvania Avenue Unit 17
L4K 4A5, Concord
+
http://www.pivotaltherapeutics.usSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+15.91% | 41.97B | |
+22.40% | 22.34B | |
+18.48% | 15.25B | |
+16.12% | 14B | |
+45.12% | 12.06B | |
-0.05% | 6.79B | |
-9.58% | 6.8B | |
-8.87% | 5.73B | |
+14.18% | 5.49B |